OBJECTIVE: Free tumor DNA in body fluids may be an important biomarker. We tested whether tumor-specific mutated p53 DNA can be detected in blood and peritoneal fluid from women with epithelial ovarian cancer. STUDY DESIGN: Sequencing of tumor DNA identified somatic p53 mutations. Free DNA from matched blood or peritoneal fluid was evaluated for the tumor-specific p53 mutation using a ligase detection reaction. RESULTS: Sixty-nine of 137 tumors (50%) had p53 mutations. Plasma or serum from 21 (30%) of the 69 informative cases contained the tumor-specific p53 mutation. Circulating tumor was an independent predictor of decreased survival in multivariate analysis (P=.02). We detected tumor DNA in peritoneal fluid in 28 of 30 (93%) cases, including all 6 cases with negative cytology. CONCLUSION: One third of women with ovarian cancer have circulating tumor DNA and an associated reduced survival. Free tumor DNA can be detected in the majority of peritoneal fluid samples.
OBJECTIVE: Free tumor DNA in body fluids may be an important biomarker. We tested whether tumor-specific mutated p53 DNA can be detected in blood and peritoneal fluid from women with epithelial ovarian cancer. STUDY DESIGN: Sequencing of tumor DNA identified somatic p53 mutations. Free DNA from matched blood or peritoneal fluid was evaluated for the tumor-specific p53 mutation using a ligase detection reaction. RESULTS: Sixty-nine of 137 tumors (50%) had p53 mutations. Plasma or serum from 21 (30%) of the 69 informative cases contained the tumor-specific p53 mutation. Circulating tumor was an independent predictor of decreased survival in multivariate analysis (P=.02). We detected tumor DNA in peritoneal fluid in 28 of 30 (93%) cases, including all 6 cases with negative cytology. CONCLUSION: One third of women with ovarian cancer have circulating tumor DNA and an associated reduced survival. Free tumor DNA can be detected in the majority of peritoneal fluid samples.
Authors: Bryan T Hennessy; Mandi Murph; Meera Nanjundan; Mark Carey; Nelly Auersperg; Jonas Almeida; Kevin R Coombes; Jinsong Liu; Yiling Lu; Joe W Gray; Gordon B Mills Journal: Adv Exp Med Biol Date: 2008 Impact factor: 2.622
Authors: Jeffrey D Krimmel; Michael W Schmitt; Maria I Harrell; Kathy J Agnew; Scott R Kennedy; Mary J Emond; Lawrence A Loeb; Elizabeth M Swisher; Rosa Ana Risques Journal: Proc Natl Acad Sci U S A Date: 2016-05-05 Impact factor: 11.205
Authors: Tilley Jenkins Vogel; Christiana Dellorusso; Piri Welcsh; Chirag A Shah; Barbara A Goff; Rochelle L Garcia; Elizabeth M Swisher Journal: Transl Oncol Date: 2012-08-01 Impact factor: 4.243
Authors: Daniel C Koboldt; Karyn Meltz Steinberg; David E Larson; Richard K Wilson; Elaine R Mardis Journal: Cell Date: 2013-09-26 Impact factor: 41.582
Authors: Avery Sonnenberg; Jennifer Y Marciniak; Elaine A Skowronski; Sareh Manouchehri; Laura Rassenti; Emanuela M Ghia; George F Widhopf; Thomas J Kipps; Michael J Heller Journal: Electrophoresis Date: 2014-05-14 Impact factor: 3.535
Authors: Qinghua Feng; Georgios Deftereos; Stephen E Hawes; Joshua E Stern; Julia B Willner; Elizabeth M Swisher; Longfu Xi; Charles Drescher; Nicole Urban; Nancy Kiviat Journal: Gynecol Oncol Date: 2008-08-30 Impact factor: 5.482